Wednesday, october 3, 2012

Wednesday November 6, 2013
Opening Ceremony – Dead Sea Hall
Thursday November 7, 2013
KEYNOTE LECTURE I: High Dose Gonadotropin Stimulation for IVF: Is it necessary and does it have a negative Effect or Outcome?*
Suheil Muasher (USA) (Wadi Rum Hall) O1
Hall: Wadi Rum
Hall: Dead Sea 1
Hall: Dead Sea 2
CONCURRENT SCIENTIFIC SESSION 1:
CONCURRENT SCIENTIFIC SESSION 2:
Poor Ovarian Reserve (O2-O4)
Menopause (O5-O7)
Predictors of Ovarian Function*
Menopause- an update on management
Delayed Puberty: Update*
consensus and controversies* Lubna Pal
Ovarian aging – how do we assess it and O6
Progestins in hormonal therapy: Options O9
The role of LH in ovarian stimulation*
what does it mean?*
and consequences*
IVF stimulation in the low ovarian
Symptom management in the
O10 Genetics and Phenotypes in Hypothalamic
reserve patient*
menopause*
Amenorrhea: Future Use of Databases for
Personalized Care* Richard Reindollar (USA)
Coffee Break
11:00
Chair
KEYNOTE LECTURE II: The Professor AboulGhar lecture (Wadi Rum) O11
Implications From The NIH-funded FASTT and FORT-T Trials For Future Infertility Care* Richard Reindollar (USA)
CONCURRENT SCIENTIFIC SESSION 4:
CONCURRENT SCIENTIFIC SESSION 5:
CONCURRENT SCIENTIFIC SESSION 6:
Assisted Reproductive Technology (O12-O14)
Fertility Preservation (O15-O17)
Endometriosis (O18-O20)
S. Khunda (IRQ), E. El-Gindy (EGY),M. Al-Jefout (JOR) O12 DNA fragmentation in sperm
Fertility preservation in female cancer
O18 Endometrial Changes in Endometriosis, do
patients: why, when, and how*
they affect implantation?
O13 Are we ready to vitrify all blastocysts in
Hormonally sensitive Cancer: Fertility
O19 Dinogest for the treatment of
eSET practice?Clinical outcomes derived
preservation stimulation protocols*
endometriosis
from closed vitrification system Elias
O14 Natural Cycle in frozen cycles
Oocyte vitrification and egg banking*
O20 Evidence-based management of
endometriosis-associated infertility
Lunch Break
14:00
Chair
S. Dabit (JOR)
M. Mahaishi (LIB), Al. Husseini (IRQ)
IPSEN- company symposium
AMS – Company Symposium
Endometriosis and IVF:"GnRH, analogue in
Highlights on Polycystic Ovarian Syndrome
Endometriosis both as pretreatment during
stimulation cycles
GnRH Agonist versus GnRH Antagonist in
Natural enhancement of conceiving by AMS
Ovarian Stimulation: “An Ongoing Debate”
KEYNOTE LECTURE III: New approaches to treat dysfunctional endometrium*
Javier Santamaria Costa (Spain) (Wadi Rum Hall) O21
MSD- Symposium
CONCURRENT SCIENTIFIC SESSION 7:
CONCURRENT SCIENTIFIC SESSION 8:
Corifollitropinalfa: From Clinical Trials to Clinical Luteal phase in ART (O22-O24)
Improving outcome of ART (O25-O27)
Practice
New Insights in Controlled Ovarian Stimulation
Impact of ovarian stimulation on the
O25 Do polymorphisms have any impact on the
luteal endometrium*
outcome in an ART program?
Integrating Corifollitropinalfa in Your Clinic
Progesterone elevation on the day of
O26 Poor ICSI outcome is associated with an
HCG administration: Ongoing debate*
increase of total CD16+ CD56+ NK
Cells and activated CD69+ NK Cells in
peripheral blood Marwan Halabi (SYR)
Simplifying luteal phase
O27 The Impact of New Technology on
supplementation for IVF*
Preimplantation Genetic Testing
Coffee Break
ORAL PRESENTATIONS SESSION 9:
ORAL PRESENTATIONS SESSION 10:
ORAL PRESENTATIONS SESSION 11:
Andrology (O28-O30)
Andrology (O31-O32)
Implantation (O33-O36)
O28 Ketotifen, a mast cell blocker improves
O31 Does prepubertal testicular tissue
O33 The best time for diagnosis of endometrial
sperm motility in asthenospermic
vitrification influence spermatogonial
polyps in TVS
infertile men
stem cells (SSCs) viability? Hemadi, M.
O29 Effect of administration of vitamins C and O32 Evaluation of Y chromosome
O34 Association study between the number of
E on fertilization capacity of rats exposed
microdeletionin Tunisian infertile men
CGG repeats in FMR1 gene with recurrent
to noise stress
abortion in Iranian patients
O30 The Detail Characteristics of Structural
O35 Thrombophilia &IVF:the unresolved
Sperm Morphology in Globozoospermia
question
O36 Letrozole; new trends in ICSI
Meeting at Exhibit
Friday November 8, 2013
KEYNOTE LECTURE IV: Techniques and Technologies for Embryo Transfer: Does it Really Matter*
Johnny Awwad (LEB) (Wadi Rum Hall) O37
CONCURRENT SCIENTIFIC SESSION 12:
CONCURRENT SCIENTIFIC SESSION 13:
CONCURRENT SCIENTIFIC SESSION 14:
Endometrial Implantation (O38-O40)
Embryology (O41-O43)
Polycystic Ovary Disease O44-O46
A. Al Shahrani (KSA), A. Oumeziane (ALG) O38 Management of unexplained Recurrent
O41 The application of non-invasive
O44 Polycystic ovary syndrome – new
Pregnancy Loss: Status of the evidence
technologies for objective embryo
perspectives on an old entity*
selection: Which one is clinically more
successful?
O39 Evidence-based strategies in Recurrent
O42 Clinical relevance of morphokinetics to
O45 Should all Women with PCOS-related
Implantation Failure: Novel approaches
assess embryo viability
Infertility be treated with Insulin
Sensitizing Drugs?*
O40 Progesterone supplementation and
O43 Selected single embryo transfer
O46 The origins of Polycystic Ovary Disease*
threatened abortion: Evidence-based or
en vogue?
Coffee Break
CONCURRENT SCIENTIFIC SESSION 15:
CONCURRENT SCIENTIFIC SESSION 16:
CONCURRENT SCIENTIFIC SESSION 17:
Outcome of ART (O47-O49)
Ovarian stimulation for ART (O50-O51)
Lifestyle in Reproductive Health
(O52-O54)
O47 Ovulation induction and multiple
O50 Cost effectiveness analysis between
O52 Ovarian aging and somatic health*
pregnancies
GnRH antagonist & Agonist : an
evidence Based approach Hesham El-
O48 Perinatal outcome of singleton
O51 Assisted reproductive technology in
O53 Relevance of vitamin D for reproduction*
pregnancies following in vitro
Egypt, 2008-2009: Results generated
fertilization
from the Egyptian IVF registry Omnia
O49 The use of vaginal progesterone for
O71 Surgical management of PCOD, is it still O54 Lifestyle Issues: Conception and
prevention of preterm birth in IVF/ICSI
an option?
pregnancy*
pregnancies
Lunch Break
H. Ayyoub (KSA), M. Ebrahim Parzanezhad (Iran) KEYNOTE LECTURE V: Aristotle – Godfather of evidence-based medicine*
Hassan Sallam (Egypt) (Wadi Rum Hall) O55
ORAL PRESENTATIONS SESSION 18:
ORAL PRESENTATIONS SESSION 19:
ORAL PRESENTATIONS SESSION 20:
Male Infertility (O56-O59)
Male Infertility (O60-O63)
Reproduction (O64-O66)
O56 The clinical significance of DNA
O60 Obesity and male fertility
O64 Reproductive performance after
fragmentation combined with semen
conservative surgical treatment of
analysis in assisted reproduction
postpartum hemorrhage
O57 Magnetic activated sperm sorting: an
O61 Mobile phone and male fertility
O65 Relationship between in vivo
effective method for in vitro reduction of
concentrations of Activin-A, Follistatin and
Sperm with DNA fragmentation in semen
AntiMüllerian ovarian hormones with
samples of infertile men undergoing
pregnancy rate following Intrauterine
assisted reproductive techniques (ART)
insemination
O58 Relationship between reactive oxygen
O62 Expression Analysis of TEX14 Gene in
O66 In vitro embryonic development following
species (ROS), malondialdehyde (MDA),
Testis Tissues of Non-obstructive
the insemination with epididymal sperms of
total antioxidants (TAS), leukocytes and
Azoospermic Iranian Infertile Men
vasectomized male mice activated in vitro
round cells in seminal plasma and their
by Glycyrrhizaglabra extract: model for
effect on sperm parameters
obstructive azoospermia
O59 Homocystein (HCY), Folic acid and
O63 Novel Indication For ART using
Vitamin (B12) levels in Follicular fluid
smuggled sperms of Palestinian
(FF) and serum of patient who became
prisoners
pregnant and those who did not after
controlled ovarian hyperstimulation
(COH) for ICSI
Coffee Break
ORAL PRESENTATIONS SESSION 21:
ORAL PRESENTATIONS SESSION 22:
Psychology (O67-O68)
Reproduction (O69-O70)
O67 The lived experience of Iranian donor
O69 Role of vaginal misoprostol in
oocyte recipient women
achieving cervical ripening before
operative hysteroscopy Elbareg, A. (Libya)
O68 Educational effectiveness in Infertility
O70 The relationship between blood group
Treatment: A Descriptive Study
and urinary tract infection in pregnancy
Meeting at Exhibit

Source: http://www.mefs.org/scientific2013.pdf

Calvin, robin, and us

Calvin, Robin, and Us This past week, I had the opportunity to attend the first annual dinner of the Calvin Coolidge Memorial Foundation as they presented their first-ever Coolidge Prize for Journalism and the Calvin Prize for Youth. I attended for two reasons: Coolidge attended St. Johnsbury Academy before entering Amherst College and his legacy is part of our legacy; and, more importantly, w

Microsoft word - potassium

The Importance of Potassium By Hans R. Larsen MSc ChE Important: Please read this entire report before acting on its findings Potassium is fairly abundant in the body with a total content of about 135 grams (3500 mmol). Most, 98% to be exact, is found inside the cells, while the remaining 2% or about 2700 mg is found outside the cells, more specifically in blood serum. Blood serum

© 2010-2017 Pharmacy Pills Pdf